A randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma

Trial Profile

A randomized phase II study comparing two schedules of temozolomide in combination with sorafenib in patients with advanced melanoma

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Sorafenib; Temozolomide
  • Indications Malignant melanoma
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 15 Dec 2009 Results have been published in the journal Clinical Cancer Research.
    • 15 Dec 2009 Status changed from active, no longer recruiting to completed. According to results published in the journal Clinical Cancer Research.
    • 14 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top